This symposium is designed for neurosurgeons, neuro-oncologists, neurologists, radiologists, medical oncologists, radiation oncologists, primary care physicians, oncology nurses, and other healthcare professionals involved in the treatment of patients with brain tumors. Additionally, patients and their caregivers, family members, advocates and members of the public who may benefit from understanding current innovative approaches to brain tumor care are invited.
At the completion of this course, participants should be able to:
- Review the new WHO classification of brain tumors and how molecular profiling affects diagnosis, MRI interpretation, prognosis and therapy of patients with gliomas
- Describe advances in the surgical treatment of brain tumors including the use of fiber tracking (DTI), awake craniotomy, brain mapping, laser thermocoagulation, and fluorescence IGS (image-guided surgery)
- Explain the role of immune system to defend against CNS malignancy including the new class of checkpoint inhibitors and the potential use of CAR-T cell therapy
- Review the benefits and application bof proton therapy for low-grade and malignant gliomas
- Describe the scientific rationale, practical application, and survival benefit of electric field therapy for malignant brain tumors
- Explain the rationale and potential for viral therapies for malignant gliomas
- Understand keys to survivorship: The patient’s journey – From the eyes and voices of actual patient heroes
- Describe recent advances in anti-angiogenic therapy in the treatment of gliomas
At the completion of this course patients and families will be able to:
- Describe the latest advances in brain cancer treatment
- Demonstrate familiarity with the terminology and technical aspects of brain cancer care
- Demonstrate patient-active behavior in working with the healthcare team to make ongoing treatment decisions
Physicians
The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Nurses
Penn Medicine Nursing is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Approval # 124-3-H-15.
Physicians
The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The program will award 6.4 contact hours.
AAPA
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 6.25 Category 1 credits for completing this activity.
The Perelman School of Medicine at the University of Pennsylvania, Office of Continuing Medical and Interprofessional Education, adheres to the ACCME Standards for Commercial Support. Faculty and planners’ disclosure information will be made available in the conference materials and syllabi. Faculty members are also expected to disclose to participants any discussion of off-label and/or investigational use of pharmaceutical products or devices within their presentations.